Where Global Innovation
and Capital Meet

Bolt hits series B with $54m

Feb 6, 2019 • Jack Hammond

Nan Fung Life Sciences and Novo have taken part in a series B round for Stanford's immuno-oncology drug developer Bolt Biotherapeutics.

Bolt Biotherapeutics, a US-based cancer therapeutics spinout of Stanford University, closed a $54m series B round yesterday featuring pharmaceutical firm Novo and Nan Fung Life Sciences, a subsidiary of property development group Nan Fung.
The round was led by Pivotal BioVenture Partners, the life science investment vehicle set up by Nan Fung, and included investment firm Vivo Capital.
Founded in 2015, Bolt is developing therapies that will fight cancer by using immune-stimulating antibody conjugates (ISACs) to reinvigorate the body’s…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

More universities adopt investor-friendly IP spinout terms

Academic institutions are taking new approaches to transferring intellectual property rights of university research in a bid to help spinouts attract investors.

Imec.xpand closes Fund II at $320m

The Belgian deep tech venture firm has surpassed its original goal by $50m and more than doubled its assets under management to $455m.

Hong Kong university seeks investors for new $64m fund

The Redbird Innovation Fund will fund spinouts emerging from the Hong Kong university.

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.